SEC Form 4 · accession 0001683168-16-000851
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Schutz
Officer — Chief Executive Officer · Director
Period of report
Nov 30, 2016
Accepted (ET)
Dec 2, 2016 · 5:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 30, 2016 | A | 3,535 | $4.81 | A | 10,040 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2 | $4.81 | Nov 30, 2016 | A | 50,000 | A | Nov 30, 2016 | Nov 30, 2026 | Common Stock | 50,000 | 103,658 | D |
Explanation of responses
- F1These shares were granted to Mr. Schutz as bonus compensation for his achievements in fiscal year 2016, based on the closing price of the Corporation's common stock of $4.81 on November 30, 2016.
- F2The stock options were granted to Mr. Schutz as a signing bonus for his employment agreement dated July 26, 2016.